CAS 2366132-45-6

Formula: C55H62N10O8

InChI: InChI=1S/C55H62N10O8/c1-34-39(12-10-14-41(34)60-49(68)35-16-20-37(21-17-35)55(2,3)4)43-33-62(5)54(73)48(59-43)58-38-22-18-36(19-23-38)51(70)64-30-28-63(29-31-64)27-9-7-6-8-26-56-46(67)32-57-42-15-11-13-40-47(42)53(72)65(52(40)71)44-24-25-45(66)61-50(44)69/h10-23,33,44,57H,6-9,24-32H2,1-5H3,(H,56,67)(H,58,59)(H,60,68)(H,61,66,69)

InChI key: QBPVFCNYKUENHU-UHFFFAOYSA-N

SMILES: CC1=C(C=CC=C1NC(=O)C2=CC=C(C=C2)C(C)(C)C)C3=CN(C(=O)C(=N3)NC4=CC=C(C=C4)C(=O)N5CCN(CC5)CCCCCCNC(=O)CNC6=CC=CC7=C6C(=O)N(C7=O)C8CCC(=O)NC8=O)C

DD 03-171

CAS: 2366132-45-6

Potent BTK Degrader, IC50=5.1nM, CRBN-dependent, suppresses MCL; degrades Ibrutinib-resistant BTK, no kinases binding, reduces tumors in models.

Formula: C₅₅H₆₂N₁₀O₈

Color and Shape: Solid

Molecular weight: 991.163

Ref: TM-T35481

DD 03-171

CAS: 2366132-45-6

Please enquire for more information about DD 03-171 including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formula: C₅₅H₆₂N₁₀O₈

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 991.1 g/mol

Ref: 3D-RUD13245

4-(tert-Butyl)-N-(3-(6-((4-(4-(6-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)acetamido)hexyl)piperazine-1-carbonyl)phenyl)amino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)benzamide

CAS: 2366132-45-6

Formula: C₅₅H₆₂N₁₀O₈

Purity: 98%

Molecular weight: 991.14

Ref: IN-DG01397583